Hydroxychloroquine for Treatment of SARS-CoV-2 Infection? Improving Our Confidence in a Model-Based Approach to Dose Selection

被引：24

作者：

Arnold, Samuel L. M. ^{[1
]}

Buckner, Frederick ^{[1
]}

机构：

[1] Univ Washington, Ctr Emerging & Reemerging Infect Dis CERID, Seattle, WA 98195 USA

来源：

CTS-CLINICAL AND TRANSLATIONAL SCIENCE | 2020年 / 13卷 / 04期

关键词：

TISSUE DISTRIBUTION; SARS CORONAVIRUS; CHLOROQUINE; PHARMACOKINETICS;

D O I：

10.1111/cts.12797

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：642 / 645

页数：4

共 18 条

[1] [Anonymous], 2020, N Engl J Med, V382, P1708, DOI [10.1056/NEJMoa2002032, 10.1101/2020.02.06.20020974, DOI 10.1101/2020.02.06.20020974]
[2] Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma
Barnard, Rebecca A.
Wittenburg, Luke A.
Amaravadi, Ravi K.
Gustafson, Daniel L.
Thorburn, Andrew
Thamm, Douglas H.
[J]. AUTOPHAGY, 2014, 10 (08) : 1415 - 1425
[3] Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia
Chen, CY
Wang, FL
Lin, CC
[J]. CLINICAL TOXICOLOGY, 2006, 44 (02) : 173 - 175
[4] Hydroxychloroquine: A Physiologically-Based Pharmacokinetic Model in the Context of Cancer-Related Autophagy Modulation
Collins, Keagan P.
Jackson, Kristen M.
Gustafson, Daniel L.
[J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2018, 365 (03) : 447 - 459
[5] MECHANISM OF ACTION OF HYDROXYCHLOROQUINE AS AN ANTIRHEUMATIC DRUG
FOX, RI
[J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 1993, 23 (02) : 82 - 91
[6] UPTAKE OF CHLOROQUINE AND HYDROXYCHLOROQUINE BY HUMAN-BLOOD LEUKOCYTES INVITRO - RELATION TO CELLULAR CONCENTRATIONS DURING ANTIRHEUMATIC THERAPY
FRENCH, JK
HURST, NP
ODONNELL, ML
BETTS, WH
[J]. ANNALS OF THE RHEUMATIC DISEASES, 1987, 46 (01) : 42 - 45
[7] Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
Gao, Jianjun
Tian, Zhenxue
Yang, Xu
[J]. BIOSCIENCE TRENDS, 2020, 14 (01) : 72 - 73
[8] Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Gautret, Philippe
Lagier, Jean-Christophe
Parola, Philippe
Van Thuan Hoang
Meddeb, Line
Mailhe, Morgane
Doudier, Barbara
Courjon, Johan
Giordanengo, Valerie
Vieira, Vera Esteves
Dupont, Herve Tissot
Honore, Stephane
Colson, Philippe
Chabriere, Eric
La Scola, Bernard
Rolain, Jean-Marc
Brouqui, Philippe
Raoult, Didier
[J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (01)
[9] Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
Hamming, I
Timens, W
Bulthuis, MLC
Lely, AT
Navis, GJ
van Goor, H
[J]. JOURNAL OF PATHOLOGY, 2004, 203 (02) : 631 - 637
[10] ANIMAL TOXICITY AND PHARMACOKINETICS OF HYDROXYCHLOROQUINE SULFATE
MCCHESNEY, EW
[J]. AMERICAN JOURNAL OF MEDICINE, 1983, 75 (1A) : 11 - 18

← 1 2 →